Clicky

Masimo Corporation(MASI)

Description: Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive patient monitoring products worldwide. The company offers Masimo Signal Extraction Technology (SET), which provides the capabilities of measure-through motion and low perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry; and Masimo rainbow SET products that monitor multiple blood measurements, including oxygen content, carboxyhemoglobin, methemoglobin, hemoglobin, pleth variability index, respiration rate, Halo Index, and In Vivo Adjustment. It develops, manufactures, and markets a family of patient monitoring solutions comprising circuit boards, monitors, sensors, and cables; Masimo Patient SafetyNet, a remote monitoring and clinician notification solution; and various software products. The company sells its products to hospitals, emergency medical response organizations, and alternate care market through its direct sales force and distributors, as well as to original equipment manufacturer partners. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.


Keywords: Medicine Medical Technology Medical Equipment Monitoring Oxygen Medical Monitoring Patient Safety Hemoglobin Perfusion Pulse Oximetry Masimo Patient Monitoring Solutions

Home Page: www.masimo.com

MASI Technical Analysis

52 Discovery
Irvine, CA 92618
United States
Phone: 949 297 7000


Officers

Name Title
Mr. Joseph E. Kiani Founder, CEO & Chairman
Mr. Micah Young Exec. VP of Fin. & CFO
Mr. Bilal Muhsin Chief Operating Officer
Mr. Thomas Samuel McClenahan Exec. VP, Gen. Counsel & Corp. Sec.
Mr. Tao Leopold Levy Exec. VP of Bus. Devel.
Mr. Yongsam Lee Exec. VP & Chief Information Officer
Dr. Steven J. Barker Chairman of Scientific Advisory Board & Chief Science Officer
Mr. Eli Kammerman VP of Bus. Devel. & Investor Relations
Mr. Jon Coleman Pres of Worldwide Sales, Professional Services & Medical Affairs
Mr. Anand Sampath Exec. VP of Operations & Clinical Research

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 40
Trailing PE: 50.6436
Price-to-Book MRQ: 6.0848
Price-to-Sales TTM: 4.3437
IPO Date: 2007-08-08
Fiscal Year End: December
Full Time Employees: 2200
Back to stocks